1.03
-0.03 (-2.83%)
| Penutupan Terdahulu | 1.06 |
| Jumlah Dagangan | 60,758 |
| Harga / Jualan (P/S) | 0.460 |
| Harga / Buku (P/B) | 0.330 |
| Julat 52 Minggu |
| Margin Keuntungan | -1.31% |
| Margin Operasi (TTM) | -2.40% |
| EPS Cair (TTM) | -0.100 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 24.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 4.89% |
| Nisbah Semasa (MRQ) | 8.16 |
| Aliran Tunai Operasi (OCF TTM) | 14.29 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 16.71 M |
| Pulangan Atas Aset (ROA TTM) | -0.63% |
| Pulangan Atas Ekuiti (ROE TTM) | -0.89% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Axonex AI Group Limited | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 1.5 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | -0.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | 2.0 |
| Persekitaran Makro | -2.8 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | 0.04 |
|
Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 1.26% |
| % Dimiliki oleh Institusi | 87.20% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |